NICE’s independent appraisal committee has asked Roche, the manufacturer of tocilizumab (RoActemra), a new treatment for moderate to severe active rheumatoid arthritis, for further additional information on its product…
Archive of posts tagged Rheumatoid Arthritis
NICE Reassessment Of Switching Decision Brings Little Hope For Rheumatoid Arthritis Patients
The National Rheumatoid Arthritis Society (NRAS) has expressed their frustration at NICE’s provisional decision not to allow patients with rheumatoid arthritis to routinely switch from one Anti-TNF drug to another. This is the second time NICE has appraised the sequential effectiveness of multiple biologic therapies following NRAS’s successful appeal of negative NICE guidance on switching in 2007…
NICE Consults On Draft Recommendations For Treating Rheumatoid Arthritis After Treatment With A TNF Inhibitor Has Failed
The National Institute for Health and Clinical Excellence (NICE) is currently appraising a number of drugs as possible treatments for rheumatoid arthritis after treatment with a tumour necrosis factor (TNF) inhibitor has failed. This is a part review of NICE technology appraisal guidance 36, and a review of NICE technology appraisal guidance 126 and 141…
Psorasis after TNF Treatment
Full article :http://arthritis-research.com/content/7/3/R666
Dermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis: a prospective studyDermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis: a prospective study© 2005 Flendrie et al.; licensee BioMed Central Ltd.
Marcel Flendrie1 email, Wynand HPM Vissers2 email, Marjonne CW Creemers1 email, Elke MGJ de Jong2 email, Peter CM [...]
SSRIs Offer Model For Drug Development Opportunities To Treat Rheumatoid Arthritis
A new study found that fluoxetine (Prozac®) and citalopram (Celexa®) treatment significantly inhibited disease progression of collagen-induced arthritis (CIA) in mice. Research led by Sandra Sacre, Ph.D…
New NICE Guidance Set To Help People With Rheumatoid Arthritis
Final guidance published today (Wednesday 24 February 2010) by the National Institute for Health and Clinical Excellence (NICE) means that another drug – certolizumab pegol (Cimzia) – can be considered for some people in England and Wales suffering with rheumatoid arthritis…
